angiotensin ii has been researched along with su 11248 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danser, AH; Kappers, MH; Sleijfer, S; Sluiter, W; van den Meiracker, AH; van Esch, JH | 1 |
Chen, H; Song, X; Zare, RN | 1 |
1 trial(s) available for angiotensin ii and su 11248
Article | Year |
---|---|
Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels.
Topics: Aged; Angiotensin II; Animals; Blood Pressure; Bradykinin; Carcinoma, Renal Cell; Cells, Cultured; Coronary Circulation; Endothelial Cells; Endothelin-1; Female; Gastrointestinal Stromal Tumors; Heart; Heart Rate; Humans; Hypertension; In Vitro Techniques; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Rats; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Renin; Sunitinib; Vascular Endothelial Growth Factor A | 2010 |
1 other study(ies) available for angiotensin ii and su 11248
Article | Year |
---|---|
Conductive Polymer Spray Ionization Mass Spectrometry for Biofluid Analysis.
Topics: Acarbose; Angiotensin II; Animals; Blood Chemical Analysis; Mass Spectrometry; Metabolomics; Mice; Nanocomposites; Nanotubes, Carbon; Polymethyl Methacrylate; Porosity; Saliva; Sunitinib; Triazines | 2018 |